Congress blocks China from buying Americans' genetic data
H.R. 2286 — American Genetic Privacy Act of 2025 · Filed by Tim Burchett (R-TN) · 4 cosponsors · Introduced Mar 24, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill prohibits the sale or disclosure of genetic information collected by commercial DNA testing services (like ancestry kits) to China or Chinese-controlled entities. It treats violations as unfair trade practices enforceable by the Federal Trade Commission, with penalties under existing FTC authority.
Why we flagged it
The bill's operative mechanism is a targeted prohibition on genetic-data transfer to a named foreign power, enforced through existing consumer-protection law. It is a national-security measure framed as privacy protection, not a broad privacy overhaul.
What the text implies
- The bill does not restrict domestic data sales or sharing among U.S. companies, meaning genetic data can still be sold to U.S. third parties, brokers, or advertisers without restriction.
- Enforcement relies on FTC's existing unfair-practice authority, which may create gaps if Chinese acquisition occurs through intermediaries, shell companies, or indirect ownership structures not clearly 'under the influence, control, or ownership' of China.
- The definition of 'covered information' is limited to data 'originally acquired' through commercial DNA testing services, potentially excluding genetic data obtained through other channels (medical records, research, direct-to-consumer non-genealogy tests).
- No private right of action is created; individuals cannot sue for violations—only the FTC can enforce, limiting individual remedy and transparency about breaches.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill protects Americans' genetic privacy from a foreign adversary without restricting citizens' rights to use DNA testing services or share data domestically. It creates a clear legal barrier against a specific national-security threat without broad surveillance or data-collection powers.
Who stands to gain
- commercial DNA testing services (23andMe, Ancestry, MyHeritage, etc.)
- U.S.-based genetic data brokers and analytics firms
Named in the bill
People's Republic of China, Federal Trade Commission, commercial DNA testing services, Genetic Information Nondiscrimination Act of 2008
Where it stands
4 cosponsors: 4 Republicans.
- Mar 24, 2025 — Introduced · Congress.gov: “Introduced in House”
- Mar 24, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (2,243 characters) on Jul 25, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Congress blocks China from buying Americans' genetic data” QuorumCivic. https://share.quorumcivic.app/bill/119/hr2286 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.